ARROWHEAD PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

ARROWHEAD PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $0.01 (loss) per share for the year ending 2025.

  • ARROWHEAD PHARMACEUTICALS, INC. showed an increase of +99.8% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from ARROWHEAD PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on November 25, 2025.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), ARROWHEAD PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 97.9%.
  • Historical annual values: Fiscal year 2025: $0.01 (loss) per share | Fiscal year 2024: $5.00 (loss) per share | Fiscal year 2023: $1.92 (loss) per share | Fiscal year 2022: $1.67 (loss) per share | Fiscal year 2021: $1.36 (loss) per share | Fiscal year 2020: $0.84 (loss) per share | Fiscal year 2019: $0.69 per share | Fiscal year 2018: $0.65 (loss) per share | Fiscal year 2017: $0.47 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: